Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines

European Journal of Medicinal Chemistry
Juan P CuevaDavid E Nichols

Abstract

Efforts to develop selective agonists for dopamine D(1)-like receptors led to the discovery of dihydrexidine and doxanthrine, two bioisosteric β-phenyldopamine-type full agonist ligands that display selectivity and potency at D(1)-like receptors. We report herein an improved methodology for the synthesis of substituted chromanoisoquinolines (doxanthrine derivatives) and the evaluation of several new compounds for their ability to bind to D(1)- and D(2)-like receptors. Identical pendant phenyl ring substitutions on the dihydrexidine and doxanthrine templates surprisingly led to different effects on D(1)-like receptor binding, suggesting important differences between the interactions of these ligands with the D(1) receptor. We propose, based on the biological results and molecular modeling studies, that slight conformational differences between the tetralin and chroman-based compounds lead to a shift in the location of the pendant ring substituents within the receptor.

References

Jan 1, 1976·Schizophrenia Bulletin·H Y Meltzer, S M Stahl
Jan 1, 1989·Movement Disorders : Official Journal of the Movement Disorder Society·G F Wooten, J M Trugman
Apr 1, 1996·Current Opinion in Neurobiology·T W Robbins, B J Everitt
Mar 14, 1997·Science·W SchultzP R Montague
Feb 20, 1998·Chemical & Pharmaceutical Bulletin·A Gonzalez De PeredoD Dauzonne
Oct 13, 1998·Neuron·G F KoobF E Bloom
Jul 18, 2001·Journal of the American Chemical Society·M C PirrungY R Lee

❮ Previous
Next ❯

Citations

Feb 24, 2015·Journal of the American Chemical Society·Gang ChenJin-Quan Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here